Organon & Co
OGN
13.79
+0.05
+0.36%
Organon & Co
US · OGN
#2364 by market cap
Listed 1970
13.79
+0.05
+0.36%
Live - 5344 symbols - heartbeat 227s ago
· 2026-10-08 07:40
Pre-market
13.79
0.00%
After-hours
13.79
0.00%
- Market cap
- 3.62B
- P/E (TTM)i
- 17.68
- P/Bi
- 3.60
- EPSi
- 0.72
- Div yieldi
- 0.58%
- 52W posi
- 100%
Reader sentiment
Are you bullish or bearish on OGN?
Anonymous reader poll. Unscientific, not investment advice.
About Organon & Co
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
- Founded
- 2020
- CEO
- Mr. Joseph T. Morrissey, Jr
- Employees
- 10,000
- Headquarters
- Jersey City, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- organon.com
Company profile
- Exchange
- US
- Symbol
- OGN
- Market-cap rank
- #2364
- Listing date
- 1970-01-01
- Market cap
- 3.62B
- Float cap
- 3.35B
- Shares out
- 262.61M
- Float shares
- 242.99M
Sectors & themes
Drug Manufacturers - General
Fractional Shares JP
Quote time 2026-10-08 07:40:25 · For reference only, not investment advice and not tailored to your situation.